Cargando…
Influence of Dehydroxymethylepoxyquinomicin on Radiosensitivity of Thyroid Carcinoma TPC-1 Cells
OBJECTIVE: To investigate the influence of dehydroxymethylepoxyquinomicin (DHMEQ), an NF-κB inhibitor, on radiosensitivity of thyroid carcinoma (TC) TPC-1 cells. METHODS: The isolation of CDl33 positive cells (CD133(+) TPC-1) and negative cells (CD133(−) TPC-1) from TPC-1 cells used immunomagnetic b...
Autores principales: | Liu, Jie, Cai, Hu, Yi, Heqing, Li, Xin, Peng, Yunsong, Li, Linfa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546666/ https://www.ncbi.nlm.nih.gov/pubmed/36213820 http://dx.doi.org/10.1155/2022/5026308 |
Ejemplares similares
-
miR-221-3p and miR-222-3p regulate the SOCS3/STAT3 signaling pathway to downregulate the expression of NIS and reduce radiosensitivity in thyroid cancer
por: Ye, Ting, et al.
Publicado: (2021) -
Assessment of radioiodine therapy efficacy for treatment of differentiated thyroid cancer patients with pulmonary metastasis undetected by chest computed tomography
por: LONG, BIN, et al.
Publicado: (2016) -
Inhibition of NF-κB by Dehydroxymethylepoxyquinomicin Suppresses Invasion and Synergistically Potentiates Temozolomide and γ-Radiation Cytotoxicity in Glioblastoma Cells
por: Brassesco, M. S., et al.
Publicado: (2013) -
Dehydroxymethylepoxyquinomicin, a novel nuclear factor-κB inhibitor, prevents the development of cyclosporine A nephrotoxicity in a rat model
por: Morita, Shinya, et al.
Publicado: (2020) -
NF-κB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor
por: Kubota, Tetsuo, et al.
Publicado: (2007)